<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>PE385605</GBSeq_locus>
    <GBSeq_length>170</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>15-FEB-2024</GBSeq_update-date>
    <GBSeq_create-date>15-FEB-2024</GBSeq_create-date>
    <GBSeq_definition>KR 1020230039669-A/20: GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF</GBSeq_definition>
    <GBSeq_primary-accession>PE385605</GBSeq_primary-accession>
    <GBSeq_accession-version>PE385605.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|PE385605.1|</GBSeqid>
      <GBSeqid>pat|KR|1020230039669|20</GBSeqid>
      <GBSeqid>gi|2677215181</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020230039669-A/20</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Adeno-associated virus</GBSeq_source>
    <GBSeq_organism>Adeno-associated virus</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..170</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Waddington,S.N.</GBAuthor>
          <GBAuthor>Karda,R.</GBAuthor>
          <GBAuthor>Herzog,C.D.</GBAuthor>
          <GBAuthor>Ng,J.</GBAuthor>
          <GBAuthor>Sacramento,C.</GBAuthor>
          <GBAuthor>Schorge,S.</GBAuthor>
          <GBAuthor>Ricks,D.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF</GBReference_title>
        <GBReference_journal>KR1020230039669-A 20 21-MAR-2023 UCL Business LTD</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020237003445-A/20~AN KR 1020237003445~AD 2023-01-30~PN KR 1020230039669~PD 2023-03-21~AT GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF~AI Waddington, Simon Nicholas|Karda, Rajvinder|Herzog,~AI Christopher Dean|Ng, Joanne|Sacramento, Chester|Schorge,~AI Stephanie|Ricks, David~AA UCL Business LTD~PR US 63/055,775=2020-07-23~OS Adeno-associated virus~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..170</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>170</GBInterval_to>
            <GBInterval_accession>PE385605.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Adeno-associated virus</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:272636</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>ctgcgcgctcgctcgctcactgaggccgcccgggcaaagcccgggcgtcgggcgacctttggtcgcccggcctcagtgagcgagcgagcgcgcagagagggagtggccaactccatcactaggggttccttgtagttaatgattaacccgccatgctacttatctacgta</GBSeq_sequence>
  </GBSeq>
